Mundipharma Oy
- L03 - Inmunoestimulantes
- PELMEG PREFILLED SYRINGE solution for injection 6 mg/0.6 ml
- N02 - Analgésicos
- NORSPAN transdermal patch 10 µg/h
- NORSPAN transdermal patch 15 µg/h
- NORSPAN transdermal patch 20 µg/h
- NORSPAN transdermal patch 25 µg/h
- NORSPAN transdermal patch 30 µg/h
- NORSPAN transdermal patch 40 µg/h
- NORSPAN transdermal patch 5 µg/h
- OXYCONTIN prolonged-release tablet 10 mg
- OXYCONTIN prolonged-release tablet 20 mg
- OXYCONTIN prolonged-release tablet 40 mg
- OXYCONTIN prolonged-release tablet 5 mg
- OXYCONTIN prolonged-release tablet 80 mg
- OXYNORM capsule, hard 10 mg
- OXYNORM capsule, hard 20 mg
- OXYNORM capsule, hard 5 mg
- OXYNORM oral drops, solution 1%
- OXYNORM oral solution 0.1%
- OXYNORM solution for injection 10 mg/1 ml
- OXYNORM solution for injection 20 mg/2 ml
- OXYNORM solution for injection 200 mg/20 ml
- PALLADON capsule, hard 1.3 mg
- PALLADON capsule, hard 2.6 mg
- PALLADON prolonged-release capsule, hard 16 mg
- PALLADON prolonged-release capsule, hard 24 mg
- PALLADON prolonged-release capsule, hard 4 mg
- PALLADON prolonged-release capsule, hard 8 mg
- PALLADON solution for injection 50 mg/ml
- TARGINIQ prolonged-release tablet 10 mg+5 mg
- TARGINIQ prolonged-release tablet 15 mg+7.5 mg
- TARGINIQ prolonged-release tablet 20 mg+10 mg
- TARGINIQ prolonged-release tablet 30 mg+15 mg
- TARGINIQ prolonged-release tablet 40 mg+20 mg
- TARGINIQ prolonged-release tablet 5 mg+25 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- AMINOCONT prolonged-release tablet 225 mg
- FLUTIFORM pressurised inhalation, suspension 10 µg/dose+250 µg/dose
- FLUTIFORM pressurised inhalation, suspension 5 µg/dose+125 µg/dose
- FLUTIFORM pressurised inhalation, suspension 5 µg/dose+50 µg/dose
- V03 - Todos los demás preparados terapéuticos
- NYXOID SINGLE DOSE nasal spray, solution 1.8 mg